DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Joensuu H, Wardelmann E, Sihto H, Eriksson M, Sundby Hall K, Reichardt A. et al.
Effect of KIT and PDGFRA mutations on survival in patients with gastrointestinal stromal tumors treated with adjuvant imatinib: An exploratory analysis of a randomized clinical trial.
JAMA Oncol 2017;
3: 602-9
We do not assume any responsibility for the contents of the web pages of other providers.